Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. (ARQT) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ARQT · as of Jun 8, 2026
Key Statistics
Explore Arcutis Biotherapeutics, Inc. Data
arqt stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 12 · Buy rate: 83.3%
The ARQT analyst consensus is Buy, based on ratings from 12 Wall Street analysts over the past 3 months. The average 12-month price target is $34.00, representing +57.85% upside from the current price of $21.54.
Competitors & Peers
arqt competitorsARQT
CELC
CGON
CNTA
FOLD
IRONStock Performance
Full HistoryAbout Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics, Inc. is a biopharmaceutical firm dedicated to developing and marketing therapies for a range of skin-related diseases. The company's flagship investigational compound, ARQ-151…
what is arcutis biotherapeutics, inc. · arqt stock overview · arcutis biotherapeutics, inc. company profile · who is arcutis biotherapeutics, inc. ceo · arqt NASDAQ · arcutis biotherapeutics, inc. headquarters · arcutis biotherapeutics, inc. business segments
About Stock Overview & Key Data
Arcutis Biotherapeutics, Inc. (ARQT) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jan 31, 2020. As of the latest trading session, ARQT stock price is $21.54, with a market capitalization of $2.7B. The stock has returned +49.58% over the past 12 months and -26.81% year-to-date.
According to 12 Wall Street analysts, the consensus rating for Arcutis Biotherapeutics, Inc. stock is Buy, with an average 12-month price target of $34.00. In fiscal year 2025, Arcutis Biotherapeutics, Inc. reported revenue of $376.1M and net income of -$16.1M. For detailed data — including Arcutis Biotherapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Arcutis Biotherapeutics, Inc. (ARQT) stock price is $21.54. The stock is traded on NASDAQ under the ticker symbol ARQT. The 52-week range is $12.72 – $31.77.